Navigation Links
UCB Announces Positive Results From Phase II Clinical Trial of Investigational Anti-Epilepsy Drug Brivaracetam
Date:12/3/2007

t fully controlled despite treatment with one or two other antiepileptic drugs. The third study is a randomized, double-blind, placebo-controlled trial with flexible dosing designed to evaluate the safety and tolerability of brivaracetam in patients with uncontrolled partial onset or primary generalized seizures. First results of these studies are expected in mid 2009.

About Brivaracetam: Brivaracetam has distinct pharmacological differences as well as having some structural similarity to the AED Keppra(R) (levetiracetam). In preclinical studies brivaracetam was shown to have a 10- fold higher affinity for synaptic vesicle protein 2A (SV2A) than Keppra(R). Brivaracetam also has inhibitory activity at neuronal voltage-dependent sodium channels whose abnormal function is understood to contribute to electrical discharges associated with seizures. These differences may explain brivaracetam's antiepileptic activity, clinical efficacy and tolerability.

About Epilepsy: Epilepsy is a chronic neurological disorder affecting more than 2.5 million Americans regardless of race, age or sex. Between 70-80% of individuals are successfully treated with one of the more than 20 antiepileptic drugs now available. However, 20-30% of patients have either intractable or uncontrolled seizures or have significant adverse side effects secondary to medication, highlighting the ongoing need for the development of new antiepileptic drugs.

About Keppra(R) in the U.S.: Keppra(R) tablets and oral solution are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy, myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. Keppra(R) injection is indicated as adjunctive therapy in the treatment of myoclonic seizures in JME
'/>"/>

SOURCE UCB, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... research suggests a link between sleep duration and ... additional hour someone with insomnia sleeps is associated ... of moderate or high risk of suicide, according ... "We were surprised by the strength of ... study author, Linden Oliver, clinical research coordinator for ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 CHI-California ... Appropriators and the California congressional delegation, joined by ... sequestered industry user fees paid to the U.S. ... ensure that future across-the-board cuts will not include ... the FY14 Agriculture, Rural Development and FDA Appropriations ...
(Date:5/24/2013)... commonly used to treat glaucoma may cause droopy eyelids ... according to a new study. The drugs, known ... eye pressure, have already been shown to cause blurred ... said, suggesting that the new findings could lead to ... conservative when prescribing these drugs, the researchers added, particularly ...
(Date:5/24/2013)... York (PRWEB) May 24, 2013 Let’s face ... It is not uncommon for the majority of people to ... it is due to a coffee addiction or simply genetics, ... whitening procedures are so popular. , Herald Square ... and very effective whitening system: Venus White Max. , ...
(Date:5/24/2013)... 24, 2013 Area homeowners dreaming about owning ... hot tubs to choose from at factory-direct pricing during the ... sales event takes place at Emerald Pool and Patio ... , Jacuzzi, the industry's leading hot tub brand, scheduled the ... country. The event will feature popular hot tub models at ...
Breaking Medicine News(10 mins):Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2
... Disguised as lymph nodes, cancer can evade detection, researchers ... research from Switzerland provides insight into how tumors remain ... nodes. , "The tumor tricks the body into thinking ... of the Laboratory of Lymphatic and Cancer Bioengineering, said ...
... Take ... , ... -- PRcheck is a totally unique formula used by Borough PR (BPR) to assess the ... clients with an accurate calculation of the amount and type of coverage that an effective ...
... ... Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, today announced ... growing training and information needs of physicians and other medical professionals interested ... site. As transradial adoption expands in the U.S., two key limiting ...
... diagnosed with breast cancer believe the risk of the disease ... times higher than it actually is. As a result, they ... perception of increased risk, according to new research. However, ... Frenchay Hospital (Bristol, UK), will tell the seventh European Breast ...
... Grove Dental, a ... convenience and services for patients , ... Chicago, IL (PRWEB) March 25, 2010 -- Grove Dental Associates, a multi-specialty dental practice ... dentist , announces the recent launch of its new Web site, www.GroveDental.com . The ...
... , ... www.megastockpicks.com ) gives it,s top buy recommendation to Pozen, Inc (NasdaqGM: POZN) upon approval of ... ... reputable internet-based free subscriber newsletter, announced today that they are initiating full coverage on pending ...
Cached Medicine News:Health News:Guaranteed PR Results from Borough PR with the New ‘PRcheck' 2Health News:U.S. Physician Demand for Transradial Access Education on the Rise New Transradial Access Site from Terumo Medical Corporation Supports Educational Need 2Health News:U.S. Physician Demand for Transradial Access Education on the Rise New Transradial Access Site from Terumo Medical Corporation Supports Educational Need 3Health News:U.S. Physician Demand for Transradial Access Education on the Rise New Transradial Access Site from Terumo Medical Corporation Supports Educational Need 4Health News:Patients requesting prophylactic mastectomies overestimate their breast cancer risk 2Health News:Patients requesting prophylactic mastectomies overestimate their breast cancer risk 3Health News:Leading Downers Grove Dentist Team at Grove Dental Launches New Web Site 2Health News:Mega Stock Picks (megastockpicks.com) Initiates Coverage on FDA Approval for POZEN, Inc.(NasdaqGM: POZN) Drug Vimovo with Immediate Buy Recommendation 2Health News:Mega Stock Picks (megastockpicks.com) Initiates Coverage on FDA Approval for POZEN, Inc.(NasdaqGM: POZN) Drug Vimovo with Immediate Buy Recommendation 3
(Date:5/23/2013)... 2013  Haemonetics Corporation (NYSE: HAE ) announced ... EVP-Business Development, will present at The Deutsche Bank 38 th ... MA on May 29, 2013 at 1:30pm Eastern ... The public may access Mr. Lindop,s presentation live via ... Haemonetics (NYSE: HAE ) is a ...
(Date:5/23/2013)... , May 23, 2013  TeamHealth Medical Call ... triage and nurse advice lines, announces its newly ... physician, nursing and administrative leaders, provides clinical expertise ... and cost-effective services for hospital clients, physician clients ... healthcare system evolves, it,s imperative to continuously advance ...
(Date:5/23/2013)... ANN ARBOR, Mich. , May 23, 2013  Every ... crucial flow of air to his lungs. April ... somehow the dire predictions weren,t true. "Quite a ... leaving the hospital alive," says April Gionfriddo ... we were desperate. Anything that would work, we would take ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4
... The Food and Drug Administration says 12 brand ... abuse, overdoses, addiction, and even deaths across the U.S. ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Find ... Sign up for e-mail notices of new FDA Consumer ...
... HILL, N.C., April 19, 2011 The oncology market ... biopharmaceutical industry, but managing all the aspects of successfully ... global strategic marketing functions supporting the oncology therapeutic area ... to run a high-performing group. Best Practices, ...
Cached Medicine Technology:Oncology Global Strategic Marketing Study Offers Chance for Resource Benchmarks 2
... Marco 35-6 TW full diameter trial lens ... for over twenty years. While maintaining only ... manufacturing process, the Marco 35-6 TW trial ... for excellence by adhering to strict industry ...
Non-Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy....
Trial Lens Sets....
... The L'Anthony 15 disc test (P/N ... for copying, and comprehensive instructions. P/N LD15C ... supply of finger tip covers for the ... and accuracy of the color discs). Beware ...
Medicine Products: